- Home
- FTFT vs ACXP Comparison
FTFT vs ACXP Comparison
Compare FTFT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ACXP
- Stock Information
- Founded
- FTFT N/A
- ACXP 2017
- Country
- FTFT United States
- ACXP United States
- Employees
- FTFT 40
- ACXP 4
- Industry
- FTFT Business Services
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- ACXP Health Care
- Exchange
- FTFT Nasdaq
- ACXP Nasdaq
- Market Cap
- FTFT 11.0M
- ACXP 6.8M
- IPO Year
- FTFT N/A
- ACXP 2021
- Fundamental
- Price
- FTFT $3.18
- ACXP $4.29
- Analyst Decision
- FTFT
- ACXP Strong Buy
- Analyst Count
- FTFT 0
- ACXP 3
- Target Price
- FTFT N/A
- ACXP $143.67
- AVG Volume (30 Days)
- FTFT 281.4K
- ACXP 73.5K
- Earning Date
- FTFT 08-19-2025
- ACXP 11-12-2025
- Dividend Yield
- FTFT N/A
- ACXP N/A
- EPS Growth
- FTFT N/A
- ACXP N/A
- EPS
- FTFT N/A
- ACXP N/A
- Revenue
- FTFT $2,368,206.00
- ACXP N/A
- Revenue This Year
- FTFT N/A
- ACXP N/A
- Revenue Next Year
- FTFT N/A
- ACXP N/A
- P/E Ratio
- FTFT N/A
- ACXP N/A
- Revenue Growth
- FTFT N/A
- ACXP N/A
- 52 Week Low
- FTFT $1.01
- ACXP $3.80
- 52 Week High
- FTFT $5.70
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- FTFT 74.35
- ACXP 38.73
- Support Level
- FTFT $2.00
- ACXP $4.02
- Resistance Level
- FTFT $3.10
- ACXP $4.27
- Average True Range (ATR)
- FTFT 0.36
- ACXP 0.53
- MACD
- FTFT 0.09
- ACXP 0.10
- Stochastic Oscillator
- FTFT 63.16
- ACXP 13.86
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.